Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for noninfectious uveitis

Mohammad O Tallouzi; Robert J Barry; Nick Bucknall; Jonathan M Mathers; Philip J Murray; Melanie J Calvert; David J Moore; Alastair K Denniston

doi:10.1002/14651858.CD012577

Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for noninfectious uveitis

Mohammad O Tallouzi, Robert J Barry, Nick Bucknall, Jonathan M Mathers, Philip J Murray, Melanie J Calvert, David J Moore, Alastair K Denniston

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

214 Downloads (Pure)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To assess the effects of anti-TNF therapy for UMO.

Original language	English
Article number	CD012577
Number of pages	14
Journal	Cochrane Database of Systematic Reviews
Volume	2017
Issue number	4
DOIs	https://doi.org/10.1002/14651858.CD012577
Publication status	Published - 11 Apr 2017

Access to Document

10.1002/14651858.CD012577Licence: None: All rights reserved

Tallouzi_et_al-2017-The_Cochrane_LibraryFinal published version, 263 KBLicence: None: All rights reserved

Cite this

@article{90a501b67ea64d038913313058feceb6,

title = "Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for noninfectious uveitis",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the effects of anti-TNF therapy for UMO.",

author = "Tallouzi, {Mohammad O} and Barry, {Robert J} and Nick Bucknall and Mathers, {Jonathan M} and Murray, {Philip J} and Calvert, {Melanie J} and Moore, {David J} and Denniston, {Alastair K}",

year = "2017",

month = apr,

day = "11",

doi = "10.1002/14651858.CD012577",

language = "English",

volume = "2017",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "Cochrane Collaboration",

number = "4",

}

TY - JOUR

T1 - Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for noninfectious uveitis

AU - Tallouzi, Mohammad O

AU - Barry, Robert J

AU - Bucknall, Nick

AU - Mathers, Jonathan M

AU - Murray, Philip J

AU - Calvert, Melanie J

AU - Moore, David J

AU - Denniston, Alastair K

PY - 2017/4/11

Y1 - 2017/4/11

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the effects of anti-TNF therapy for UMO.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the effects of anti-TNF therapy for UMO.

UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-85018461786&partnerID=MN8TOARS

U2 - 10.1002/14651858.CD012577

DO - 10.1002/14651858.CD012577

M3 - Article

SN - 1469-493X

VL - 2017

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 4

M1 - CD012577

ER -

Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for noninfectious uveitis

Abstract

Access to Document

Fingerprint

Cite this